Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Review ArticlePerspective

Deactivation of Vasodilator Responses by GRK2 Overexpression:A Mechanism or the Mechanism for Hypertension?

Ross D. Feldman
Molecular Pharmacology April 2002, 61 (4) 707-709; DOI: https://doi.org/10.1124/mol.61.4.707
Ross D. Feldman
Robarts Research Institute, London, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 61 no. 4 707-709
DOI 
https://doi.org/10.1124/mol.61.4.707
PubMed 
11901207

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received February 6, 2002
  • Accepted February 7, 2002
  • Published online April 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Ross D. Feldman
  1. Robarts Research Institute, London, Ontario, Canada
  1. Ross D. Feldman, Robarts Research Institute, P.O. Box 5015, 100 Perth Drive, London, ON, Canada N6A 5K8. E-mail: feldmanr{at}lhsc.on.ca

Statistics from Altmetric.com

Article usage

Article usage: March 2002 to August 2023

AbstractFullPdf
Mar 200209683
Apr 200206653
May 200223129
Jun 200201212
Jul 200201618
Aug 2002054
Sep 20020138
Oct 20020108
Nov 2002065
Dec 2002055
Jan 2003096
Feb 2003066
Mar 20030104
Apr 20030927
May 2003058
Jun 2003070
Jul 20030149
Aug 20030131
Sep 20030208
Oct 20030196
Nov 20030205
Dec 20030145
Jan 20040276
Feb 20040187
Mar 20040174
Apr 20040123
May 20040197
Jun 20040166
Jul 20040194
Aug 20040177
Sep 20040197
Oct 20040216
Nov 20040113
Dec 20040132
Jan 20050202
Feb 20050230
Mar 20051162
Apr 20050101
May 20050153
Jun 20050103
Jul 20051159
Aug 2005182
Sep 200501314
Oct 20050126
Nov 2005194
Dec 20050104
Jan 20060174
Feb 20060103
Mar 20060114
Apr 2006023
May 20060100
Jun 2006076
Jul 2006051
Aug 2006042
Sep 2006063
Oct 2006092
Nov 20060103
Dec 2006021
Jan 2007044
Feb 2007031
Mar 2007052
Apr 2007083
May 2007084
Jun 2007097
Jul 2007035
Aug 2007091
Sep 2007076
Oct 20070123
Nov 2007085
Dec 2007064
Jan 2008040
Feb 2008056
Mar 2008062
Apr 2008096
May 2008013
Jun 20080183
Jul 200801111
Aug 20080121
Sep 20080211
Oct 2008082
Nov 2008094
Dec 20080149
Jan 2009041
Feb 2009061
Mar 2009022
Apr 2009064
May 2009090
Jun 2009090
Jul 2009052
Aug 2009042
Sep 2009020
Oct 2009044
Nov 2009020
Dec 2009040
Jan 2010013
Feb 2010021
Mar 2010040
Apr 2010054
May 2010033
Jun 2010037
Jul 2010057
Aug 2010051
Sep 2010011
Oct 2010066
Nov 2010054
Dec 2010030
Jan 2011033
Feb 2011066
Mar 2011057
Apr 2011033
May 2011044
Jun 2011051
Jul 2011093
Aug 2011055
Sep 2011090
Oct 20110913
Nov 20110111
Dec 20110111
Jan 20120101
Feb 2012094
Mar 20120118
Apr 2012098
May 2012072
Jun 2012042
Jul 20120151
Aug 2012055
Sep 2012052
Oct 2012093
Nov 2012010404
Dec 2012058
Jan 2013093
Feb 2013044
Mar 20130134
Apr 20130104
May 2013093
Jun 2013020
Jul 2013023
Aug 2013043
Sep 2013010
Oct 2013031
Nov 2013013
Dec 2013010
Feb 2014057
Mar 2014069
Apr 2014072
May 20140105
Jun 2014021
Jul 2014087
Aug 2014024
Sep 2014023
Oct 2014095
Nov 2014071
Dec 2014054
Jan 2015021
Feb 2015059
Mar 20150611
Apr 2015022
May 2015092
Jun 2015070
Jul 20150268
Aug 20150101
Sep 20150122
Oct 2015042
Nov 2015072
Dec 2015052
Jan 2016073
Feb 20160173
Mar 2016062
Apr 2016053
May 20160102
Jun 2016063
Jul 2016071
Aug 2016005
Sep 2016040
Oct 2016061
Nov 2016091
Dec 2016051
Jan 20170101
Feb 2017080
Mar 2017060
Apr 20170100
May 2017081
Jun 2017052
Jul 2017020
Aug 2017061
Sep 2017020
Oct 2017061
Nov 20170113
Dec 2017080
Jan 2018061
Feb 2018072
Mar 20180143
Apr 20180100
May 20180260
Jun 20180221
Jul 20180220
Aug 2018060
Sep 2018052
Oct 2018090
Nov 20180152
Mar 2019011
Jun 2019002
Mar 2020010
Aug 2020013
Sep 2020010
Oct 2020020
Nov 2020010
Jan 2021010
Feb 2021031
Mar 2021010
Apr 2021010
May 2021021
Jun 2021010
Jul 2021010
Aug 2021010
Sep 2021010
Oct 2021010
Nov 2021010
Jan 2022010
Feb 2022010
Mar 2022020
Apr 2022010
May 2022010
Jun 2022010
Jul 2022010
Sep 2022010
Oct 2022010
Nov 2022010
Dec 2022010
Jan 2023010
Mar 2023010
Apr 2023010
Jun 2023010
Aug 2023010

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 61 (4)
Molecular Pharmacology
Vol. 61, Issue 4
1 Apr 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Deactivation of Vasodilator Responses by GRK2 Overexpression:A Mechanism or the Mechanism for Hypertension?
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticlePerspective

Deactivation of Vasodilator Responses by GRK2 Overexpression:A Mechanism or the Mechanism for Hypertension?

Ross D. Feldman
Molecular Pharmacology April 1, 2002, 61 (4) 707-709; DOI: https://doi.org/10.1124/mol.61.4.707

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Review ArticlePerspective

Deactivation of Vasodilator Responses by GRK2 Overexpression:A Mechanism or the Mechanism for Hypertension?

Ross D. Feldman
Molecular Pharmacology April 1, 2002, 61 (4) 707-709; DOI: https://doi.org/10.1124/mol.61.4.707
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • Abbreviations
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Coronavirus in the Brain and the Impact of Smoking
  • G Protein Signaling Then and Now: A Tribute to Al Gilman
  • Cellular Assays Detect Pluridimensional and Biased Efficacy
Show more Perspective

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics